<?xml version="1.0" encoding="utf-8"?>
<legaldoc>
<law type="statute"><section id="id476"><amendatorysection statutenumber="71-9603" chaptername="Public Health and Welfare"><bookinfo>Reissue Revised Statutes of Nebraska</bookinfo><statuteno>71-9603</statuteno><catchline>Eligible patient.</catchline><para>To be an eligible patient under the Investigational Drug Use Act, a person shall:</para><para>(1) Have an advanced illness, attested by the person's treating physician;</para><para>(2) Have considered all other treatment options approved by the United States Food and Drug Administration at the time;</para><para>(3) Have a recommendation from his or her treating physician for an investigational drug, biological product, or device;</para><para>(4) Give written, informed consent for the use of the investigational drug, biological product, or device;</para><para>(5) Have documentation from his or her treating physician that he or she meets the requirements of the act; and</para><para>(6) Not be a patient receiving inpatient treatment in a hospital licensed pursuant to the Health Care Facility Licensure Act.</para></amendatorysection></section><source><para>Laws 2018, LB117, &#167; 3. </para></source><crossreference><para><emphasis>Health Care Facility Licensure Act,</emphasis> see section 71-401.</para></crossreference></law>
</legaldoc>